Cita APA

Otani, Y., Namagiri, S., Thammegowda, S., Sur, H., Chowdhury, A., Lewis, C., . . . Banasavadi-Siddegowda, Y. K. (2020). CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT. Neuro Oncol.

Chicago Style Citation

Otani, Yoshihiro, et al. "CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT." Neuro Oncol 2020.

Cita MLA

Otani, Yoshihiro, et al. "CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT." Neuro Oncol 2020.